Yoga for symptom management in oncology

A review of the evidence base and future directions for research

Suzanne C. Danhauer*, Elizabeth L. Addington, Lorenzo Cohen, Stephanie J. Sohl, Marieke Van Puymbroeck, Natalia K. Albinati, S. Nicole Culos-Reed

*Corresponding author for this work

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Because yoga is increasingly recognized as a complementary approach to cancer symptom management, patients/survivors and providers need to understand its potential benefits and limitations both during and after treatment. The authors reviewed randomized controlled trials (RCTs) of yoga conducted at these points in the cancer continuum (N = 29; n = 13 during treatment, n = 12 post-treatment, and n = 4 with mixed samples). Findings both during and after treatment demonstrated the efficacy of yoga to improve overall quality of life (QOL), with improvement in subdomains of QOL varying across studies. Fatigue was the most commonly measured outcome, and most RCTs conducted during or after cancer treatment reported improvements in fatigue. Results also suggested that yoga can improve stress/distress during treatment and post-treatment disturbances in sleep and cognition. Several RCTs provided evidence that yoga may improve biomarkers of stress, inflammation, and immune function. Outcomes with limited or mixed findings (eg, anxiety, depression, pain, cancer-specific symptoms, such as lymphedema) and positive psychological outcomes (such as benefit-finding and life satisfaction) warrant further study. Important future directions for yoga research in oncology include: enrolling participants with cancer types other than breast, standardizing self-report assessments, increasing the use of active control groups and objective measures, and addressing the heterogeneity of yoga interventions, which vary in type, key components (movement, meditation, breathing), dose, and delivery mode.

Original languageEnglish (US)
Pages (from-to)1979-1989
Number of pages11
JournalCancer
Volume125
Issue number12
DOIs
StatePublished - Jun 15 2019

Fingerprint

Yoga
Research
Randomized Controlled Trials
Fatigue
Therapeutics
Quality of Life
Meditation
Neoplasms
Lymphedema
Direction compound
Self Report
Cognition
Survivors
Sleep
Respiration
Anxiety
Biomarkers
Depression
Breast Neoplasms
Psychology

Keywords

  • anxiety
  • cancer
  • depression
  • fatigue
  • mind-body
  • quality of life
  • sleep
  • symptoms
  • yoga

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Danhauer, S. C., Addington, E. L., Cohen, L., Sohl, S. J., Van Puymbroeck, M., Albinati, N. K., & Culos-Reed, S. N. (2019). Yoga for symptom management in oncology: A review of the evidence base and future directions for research. Cancer, 125(12), 1979-1989. https://doi.org/10.1002/cncr.31979
Danhauer, Suzanne C. ; Addington, Elizabeth L. ; Cohen, Lorenzo ; Sohl, Stephanie J. ; Van Puymbroeck, Marieke ; Albinati, Natalia K. ; Culos-Reed, S. Nicole. / Yoga for symptom management in oncology : A review of the evidence base and future directions for research. In: Cancer. 2019 ; Vol. 125, No. 12. pp. 1979-1989.
@article{4385c9e0bcfe49f8bd978c7aaed4d0f7,
title = "Yoga for symptom management in oncology: A review of the evidence base and future directions for research",
abstract = "Because yoga is increasingly recognized as a complementary approach to cancer symptom management, patients/survivors and providers need to understand its potential benefits and limitations both during and after treatment. The authors reviewed randomized controlled trials (RCTs) of yoga conducted at these points in the cancer continuum (N = 29; n = 13 during treatment, n = 12 post-treatment, and n = 4 with mixed samples). Findings both during and after treatment demonstrated the efficacy of yoga to improve overall quality of life (QOL), with improvement in subdomains of QOL varying across studies. Fatigue was the most commonly measured outcome, and most RCTs conducted during or after cancer treatment reported improvements in fatigue. Results also suggested that yoga can improve stress/distress during treatment and post-treatment disturbances in sleep and cognition. Several RCTs provided evidence that yoga may improve biomarkers of stress, inflammation, and immune function. Outcomes with limited or mixed findings (eg, anxiety, depression, pain, cancer-specific symptoms, such as lymphedema) and positive psychological outcomes (such as benefit-finding and life satisfaction) warrant further study. Important future directions for yoga research in oncology include: enrolling participants with cancer types other than breast, standardizing self-report assessments, increasing the use of active control groups and objective measures, and addressing the heterogeneity of yoga interventions, which vary in type, key components (movement, meditation, breathing), dose, and delivery mode.",
keywords = "anxiety, cancer, depression, fatigue, mind-body, quality of life, sleep, symptoms, yoga",
author = "Danhauer, {Suzanne C.} and Addington, {Elizabeth L.} and Lorenzo Cohen and Sohl, {Stephanie J.} and {Van Puymbroeck}, Marieke and Albinati, {Natalia K.} and Culos-Reed, {S. Nicole}",
year = "2019",
month = "6",
day = "15",
doi = "10.1002/cncr.31979",
language = "English (US)",
volume = "125",
pages = "1979--1989",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

Danhauer, SC, Addington, EL, Cohen, L, Sohl, SJ, Van Puymbroeck, M, Albinati, NK & Culos-Reed, SN 2019, 'Yoga for symptom management in oncology: A review of the evidence base and future directions for research', Cancer, vol. 125, no. 12, pp. 1979-1989. https://doi.org/10.1002/cncr.31979

Yoga for symptom management in oncology : A review of the evidence base and future directions for research. / Danhauer, Suzanne C.; Addington, Elizabeth L.; Cohen, Lorenzo; Sohl, Stephanie J.; Van Puymbroeck, Marieke; Albinati, Natalia K.; Culos-Reed, S. Nicole.

In: Cancer, Vol. 125, No. 12, 15.06.2019, p. 1979-1989.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Yoga for symptom management in oncology

T2 - A review of the evidence base and future directions for research

AU - Danhauer, Suzanne C.

AU - Addington, Elizabeth L.

AU - Cohen, Lorenzo

AU - Sohl, Stephanie J.

AU - Van Puymbroeck, Marieke

AU - Albinati, Natalia K.

AU - Culos-Reed, S. Nicole

PY - 2019/6/15

Y1 - 2019/6/15

N2 - Because yoga is increasingly recognized as a complementary approach to cancer symptom management, patients/survivors and providers need to understand its potential benefits and limitations both during and after treatment. The authors reviewed randomized controlled trials (RCTs) of yoga conducted at these points in the cancer continuum (N = 29; n = 13 during treatment, n = 12 post-treatment, and n = 4 with mixed samples). Findings both during and after treatment demonstrated the efficacy of yoga to improve overall quality of life (QOL), with improvement in subdomains of QOL varying across studies. Fatigue was the most commonly measured outcome, and most RCTs conducted during or after cancer treatment reported improvements in fatigue. Results also suggested that yoga can improve stress/distress during treatment and post-treatment disturbances in sleep and cognition. Several RCTs provided evidence that yoga may improve biomarkers of stress, inflammation, and immune function. Outcomes with limited or mixed findings (eg, anxiety, depression, pain, cancer-specific symptoms, such as lymphedema) and positive psychological outcomes (such as benefit-finding and life satisfaction) warrant further study. Important future directions for yoga research in oncology include: enrolling participants with cancer types other than breast, standardizing self-report assessments, increasing the use of active control groups and objective measures, and addressing the heterogeneity of yoga interventions, which vary in type, key components (movement, meditation, breathing), dose, and delivery mode.

AB - Because yoga is increasingly recognized as a complementary approach to cancer symptom management, patients/survivors and providers need to understand its potential benefits and limitations both during and after treatment. The authors reviewed randomized controlled trials (RCTs) of yoga conducted at these points in the cancer continuum (N = 29; n = 13 during treatment, n = 12 post-treatment, and n = 4 with mixed samples). Findings both during and after treatment demonstrated the efficacy of yoga to improve overall quality of life (QOL), with improvement in subdomains of QOL varying across studies. Fatigue was the most commonly measured outcome, and most RCTs conducted during or after cancer treatment reported improvements in fatigue. Results also suggested that yoga can improve stress/distress during treatment and post-treatment disturbances in sleep and cognition. Several RCTs provided evidence that yoga may improve biomarkers of stress, inflammation, and immune function. Outcomes with limited or mixed findings (eg, anxiety, depression, pain, cancer-specific symptoms, such as lymphedema) and positive psychological outcomes (such as benefit-finding and life satisfaction) warrant further study. Important future directions for yoga research in oncology include: enrolling participants with cancer types other than breast, standardizing self-report assessments, increasing the use of active control groups and objective measures, and addressing the heterogeneity of yoga interventions, which vary in type, key components (movement, meditation, breathing), dose, and delivery mode.

KW - anxiety

KW - cancer

KW - depression

KW - fatigue

KW - mind-body

KW - quality of life

KW - sleep

KW - symptoms

KW - yoga

UR - http://www.scopus.com/inward/record.url?scp=85063668961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063668961&partnerID=8YFLogxK

U2 - 10.1002/cncr.31979

DO - 10.1002/cncr.31979

M3 - Review article

VL - 125

SP - 1979

EP - 1989

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 12

ER -